KeyCorp Analysts Give Envision Healthcare Corporation (EVHC) a $67.00 Price Target

KeyCorp set a $67.00 price target on Envision Healthcare Corporation (NYSE:EVHC) in a research note issued to investors on Wednesday morning. The brokerage currently has a buy rating on the stock.

EVHC has been the subject of a number of other reports. Robert W. Baird reaffirmed a buy rating and set a $70.00 price objective on shares of Envision Healthcare Corporation in a research note on Tuesday, October 17th. Cantor Fitzgerald reaffirmed a buy rating and set a $80.00 price objective on shares of Envision Healthcare Corporation in a research note on Tuesday, July 4th. Zacks Investment Research raised Envision Healthcare Corporation from a strong sell rating to a buy rating and set a $70.00 price objective for the company in a research note on Tuesday, July 4th. Jefferies Group LLC set a $71.00 price objective on Envision Healthcare Corporation and gave the stock a buy rating in a research note on Thursday, August 24th. Finally, BidaskClub cut Envision Healthcare Corporation from a hold rating to a sell rating in a research note on Tuesday, August 1st. Two analysts have rated the stock with a sell rating, five have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. Envision Healthcare Corporation presently has an average rating of Buy and an average price target of $49.21.

Shares of Envision Healthcare Corporation (NYSE EVHC) opened at $27.04 on Wednesday. The company has a market capitalization of $3,267.14, a price-to-earnings ratio of 8.35, a PEG ratio of 0.57 and a beta of 0.69. Envision Healthcare Corporation has a 52 week low of $26.56 and a 52 week high of $74.75. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 2.82.

Envision Healthcare Corporation (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare Corporation had a negative net margin of 6.39% and a positive return on equity of 4.88%. The firm’s quarterly revenue was up 142.0% on a year-over-year basis. During the same period last year, the business posted $1.13 earnings per share. sell-side analysts predict that Envision Healthcare Corporation will post 3.12 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.com-unik.info/2017/11/05/keycorp-analysts-give-envision-healthcare-corporation-evhc-a-67-00-price-target.html.

Envision Healthcare Corporation announced that its Board of Directors has approved a share repurchase plan on Monday, September 18th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 4.5% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board of directors believes its stock is undervalued.

Several institutional investors have recently modified their holdings of EVHC. Teachers Advisors LLC lifted its holdings in shares of Envision Healthcare Corporation by 1.0% in the first quarter. Teachers Advisors LLC now owns 329,462 shares of the company’s stock valued at $20,203,000 after purchasing an additional 3,230 shares in the last quarter. New York State Teachers Retirement System lifted its holdings in shares of Envision Healthcare Corporation by 4.5% in the first quarter. New York State Teachers Retirement System now owns 95,987 shares of the company’s stock valued at $5,886,000 after purchasing an additional 4,109 shares in the last quarter. Paloma Partners Management Co lifted its holdings in shares of Envision Healthcare Corporation by 37.6% in the first quarter. Paloma Partners Management Co now owns 8,514 shares of the company’s stock valued at $522,000 after purchasing an additional 2,328 shares in the last quarter. HighTower Advisors LLC lifted its holdings in shares of Envision Healthcare Corporation by 5.6% in the first quarter. HighTower Advisors LLC now owns 4,541 shares of the company’s stock valued at $274,000 after purchasing an additional 240 shares in the last quarter. Finally, OLD Mutual Customised Solutions Proprietary Ltd. lifted its holdings in shares of Envision Healthcare Corporation by 54.5% in the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 3,401 shares of the company’s stock valued at $209,000 after purchasing an additional 1,200 shares in the last quarter.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

What are top analysts saying about Envision Healthcare Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit